539 related articles for article (PubMed ID: 28666115)
41. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
42. Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches.
Ramani V; Teshima T; Tamura K; Chung JS; Kobayashi M; Cruz PD; Ariizumi K
J Invest Dermatol; 2018 Nov; 138(11):2443-2451. PubMed ID: 29857071
[TBL] [Abstract][Full Text] [Related]
43. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
44. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
[TBL] [Abstract][Full Text] [Related]
45. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
[TBL] [Abstract][Full Text] [Related]
46. Ongoing adaptive immune responses in the microenvironment of melanoma metastases.
van Baren N; Coulie PG
Ann N Y Acad Sci; 2013 May; 1284():62-5. PubMed ID: 23651195
[TBL] [Abstract][Full Text] [Related]
47. Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.
Yan BY; Garcet S; Gulati N; Kiecker F; Fuentes-Duculan J; Gilleaudeau P; Sullivan-Whalen M; Shemer A; Mitsui H; Krueger JG
Exp Dermatol; 2019 Jan; 28(1):35-44. PubMed ID: 30326165
[TBL] [Abstract][Full Text] [Related]
48. Interferon-γ Drives T
Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
[TBL] [Abstract][Full Text] [Related]
49. Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regression.
Verma V; Kim Y; Lee MC; Lee JT; Cho S; Park IK; Min JJ; Lee JJ; Lee SE; Rhee JH
Oncotarget; 2016 Jun; 7(26):39894-39906. PubMed ID: 27223090
[TBL] [Abstract][Full Text] [Related]
50. Single-cell analysis reveals new evolutionary complexity in uveal melanoma.
Durante MA; Rodriguez DA; Kurtenbach S; Kuznetsov JN; Sanchez MI; Decatur CL; Snyder H; Feun LG; Livingstone AS; Harbour JW
Nat Commun; 2020 Jan; 11(1):496. PubMed ID: 31980621
[TBL] [Abstract][Full Text] [Related]
51. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity.
Sckisel GD; Bouchlaka MN; Monjazeb AM; Crittenden M; Curti BD; Wilkins DE; Alderson KA; Sungur CM; Ames E; Mirsoian A; Reddy A; Alexander W; Soulika A; Blazar BR; Longo DL; Wiltrout RH; Murphy WJ
Immunity; 2015 Aug; 43(2):240-50. PubMed ID: 26231116
[TBL] [Abstract][Full Text] [Related]
52. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL
Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581
[TBL] [Abstract][Full Text] [Related]
53. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.
Shen L; Evel-Kabler K; Strube R; Chen SY
Nat Biotechnol; 2004 Dec; 22(12):1546-53. PubMed ID: 15558048
[TBL] [Abstract][Full Text] [Related]
54. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease.
Mulder K; Patel AA; Kong WT; Piot C; Halitzki E; Dunsmore G; Khalilnezhad S; Irac SE; Dubuisson A; Chevrier M; Zhang XM; Tam JKC; Lim TKH; Wong RMM; Pai R; Khalil AIS; Chow PKH; Wu SZ; Al-Eryani G; Roden D; Swarbrick A; Chan JKY; Albani S; Derosa L; Zitvogel L; Sharma A; Chen J; Silvin A; Bertoletti A; Blériot C; Dutertre CA; Ginhoux F
Immunity; 2021 Aug; 54(8):1883-1900.e5. PubMed ID: 34331874
[TBL] [Abstract][Full Text] [Related]
55. HIV-1 transactivator protein induction of suppressor of cytokine signaling-2 contributes to dysregulation of IFN{gamma} signaling.
Cheng SM; Li JC; Lin SS; Lee DC; Liu L; Chen Z; Lau AS
Blood; 2009 May; 113(21):5192-201. PubMed ID: 19279332
[TBL] [Abstract][Full Text] [Related]
56. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
57. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
Movassagh M; Spatz A; Davoust J; Lebecque S; Romero P; Pittet M; Rimoldi D; Liénard D; Gugerli O; Ferradini L; Robert C; Avril MF; Zitvogel L; Angevin E
Cancer Res; 2004 Mar; 64(6):2192-8. PubMed ID: 15026362
[TBL] [Abstract][Full Text] [Related]
58. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Greaney SK; Algazi AP; Tsai KK; Takamura KT; Chen L; Twitty CG; Zhang L; Paciorek A; Pierce RH; Le MH; Daud AI; Fong L
Cancer Immunol Res; 2020 Feb; 8(2):246-254. PubMed ID: 31852717
[TBL] [Abstract][Full Text] [Related]
59. Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.
Donia M; Harbst K; van Buuren M; Kvistborg P; Lindberg MF; Andersen R; Idorn M; Munir Ahmad S; Ellebæk E; Mueller A; Fagone P; Nicoletti F; Libra M; Lauss M; Hadrup SR; Schmidt H; Andersen MH; Thor Straten P; Nilsson JA; Schumacher TN; Seliger B; Jönsson G; Svane IM
Cancer Res; 2017 Sep; 77(17):4562-4566. PubMed ID: 28655789
[TBL] [Abstract][Full Text] [Related]
60. Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
Hsueh EC; Famatiga E; Shu S; Ye X; Morton DL
Ann Surg Oncol; 2004 Oct; 11(10):892-9. PubMed ID: 15383418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
